Abstract: A portable, handheld device for forensic analysis includes an input unit configured to receive a forensic input at a scene of forensic analysis, and a processing unit. The processing unit is configured to generate a first image of the forensic input, scale the first image to a predetermined format suitable for forensic analysis, generate a second image of the forensic input in which the first image is scaled to the predetermined format, compare the second image with forensic records, which each respectively include previously collected forensic data associated with one or more individuals or specimens, determine whether the second image matches at least a portion of one of the forensic records, upon determining that the second image matches at least a portion of one of the forensic records, generate a matching notification identifying the record which the second image is determined to match, and output the generated matching notification.

Abstract: A portable, handheld device for forensic analysis that includes: an input unit configured to receive a forensic input at a scene of forensic analysis; and a processing unit configured to generate a first image of the forensic input, scale the first image to a predetermined format suitable for forensic analysis, and generate a second image of the forensic input in which the first image is scaled to the predetermined format, compare the second image with forensic records, each forensic record including previously collected forensic data associated with one or more individuals or specimens, determine whether the second image matches at least a portion of one of the forensic records, upon determining that the second image matches at least a portion of one of the forensic records, generate a matching notification identifying the record which the second image is determined to match, and output the generated matching notification.

Abstract: The invention describes the use of dendritic cell vaccines, wherein SHP-1 expression or activity is modulated in the dendritic cell. In particular, the invention provides dendritic cells (DC) transduced with an SHP1-shRNA adenovirus, or dominant negative (dn-SHP-1) or constitutively active (ca-SHP-1), and pulsed with an antigen. The methods and compositions of the invention are used for the prevention and/or treatment of cancers, other cell proliferation diseases and conditions, diseases caused by a pathogen, or autoimmune disorders.

Abstract: The present invention regards expression profiles of one or more nucleic acids indicative of the presence of, susceptibility to, and/or predicting response to therapy of benign prostatic hyperplasia (BPH) in an individual. The present invention identifies pathways not previously associated with BPH, therefore presenting novel diagnostic and therapeutic targets for the condition.